Cannabis Law Report

JANUARY 24, 2022

(NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today the appointment of world-renowned cannabis genetics and cultivation expert Derek Pedro as an advisor to its Cosechemos cultivation facility.

Cultivation 52

Cultivation Wellness and Beauty Research and Development Events 52

Veriheal

APRIL 14, 2022

France has officially permitted medical cannabis production and cultivation. France’s Medical Cannabis Decree to be Overseen by ANSM. Prior to the decree’s publication, France had already been busy importing cannabis products for its medical cannabis pilot program.

Cultivation 52

Cultivation Supply Chain Research and Development Programs 52

Cannabis Law Report

SEPTEMBER 16, 2022

Free cannabis testing for ACT home-growers. University to study cannabis use and cultivation in the ACT. A study will examine home-grown cannabis in the Australian Capital Territory for medicinal and non/medicinal purposes. The goal is to investigate cannabis consumption, behaviours and attitudes among users.

Cultivation 52

Cultivation Pharmaceutical Cannabinoids Medicine 52

Freedom Leaf

APRIL 24, 2019

With the array of cannabis legalization laws taking effect in the U.S. By becoming your own master cultivator, you gain autonomy throughout the entire growth process, ensuring both safety and quality. Home cultivation can improve your health and wellness. It’s the Era of the Grow Gadget.

Cultivation 60

Cultivation Hydroponic Pharmaceutical Cannabis 60

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will use TruTrace’s blockchain-enabled platform for seed-to-sale tracking of its cannabis products – including integration of Applied DNA’s molecular tagging technology – to offer Flora’s customers a complete product validation and authentication solution. CSE: TTT; OTCQB: TTTSF) (“TruTrace”) and Applied DNA Sciences, Inc.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Cannabis Law Report

JULY 2, 2021

Chulalongkorn University has established the “Chula Cannabis and its Natural Substances (Chula C.A.N.S.) Rungpetch Sakulbumrungsilp Dean of the Faculty of Pharmaceutical Sciences, Chulalongkorn University. very little research on cannabis has been carried out during the 10 years before its legalization. According to Asst.

Research and Development 105

Research and Development Pharmaceutical Extraction Seed-To-Sale 105

SpeedWeed

FEBRUARY 28, 2021

Innovation in the cannabis industry is accelerating, with creative entrepreneurs developing emulsions, fast-acting formulas and other delivery enhancements for an ever-expanding universe of products. All this is happening while pharmaceutical chemists are preparing cannabis-based medicines for U.S.

Cultivation 52

Cultivation Business Marijuana Pharmaceutical 52

Cannabis Law Report

MAY 29, 2019

The research will focus on the optimisation of breeding and cultivating processes and the extraction of material to assess their efficacy of medical cannabis on prostate, melanoma and other cancer cells. Here’s the press release. All intellectual property from the trials will be owned by MGC, which is funding the research.

Cultivation 40

Cultivation Pharmaceutical Clinical Trials Extraction 40

Cannabis Law Report

JULY 21, 2019

ICC International Cannabis Corp. FWB: 8K51)(OTC: WLDCF) (the “Company” or “ ICC ” or “ International Cannabis”) is pleased to announce that the Company has entered into an exclusive supply and commercial rights agreement (the “Agreement”) with licensed New Zealand medical cannabis company, NUBU Pharmaceuticals (“NUBU”).

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

JULY 19, 2019

July 18, 2019 (GLOBE NEWSWIRE) — ICC International Cannabis Corp. Under the terms of the Agreement, ICC will supply NUBU will a suite of full-spectrum pharmaceutical grade medical cannabis products including: Packaged and labelled medical cannabis including; oil/tincture and capsules in finished goods form.

Pharmaceutical 40

Pharmaceutical THC CBD Supply Chain 40

Cannabis Law Report

AUGUST 1, 2021

GREEK businesses are preparing for amendments to the Mediterranean country’s cannabis laws allowing the cultivation, sale and export of high percentage THC medical products. Tetrahydrocannabinol (THC). Tetrahydrocannabinol (THC).

Sativa 105

Sativa Pharmaceutical Extraction Cultivation 105

Cannabis Law Report

MAY 30, 2019

(CSE: BBT) (FSE: BBW) (OTC Pink: BHHKF) (“Benchmark”, “BBT” or the “Company”) a federally-licensed producer and distributor of medical-grade cannabis, is pleased to report that it has signed a definitive agreement with China-based Zhejiang Yatai Pharmaceutical Co.,

Pharmaceutical 40

Pharmaceutical Research and Development Extraction Cultivation 40

Cannabis Law Report

JULY 23, 2019

(TSXV: LG and OTC-QB: LGGCF) (“ LGC ”) is pleased to announce that it has paid the 2 nd Tranche, as contractually agreed, in acquiring an equity interest in the Italian pharmaceutical company, Freia Farmaceutici Srl (“Freia”). This EU pharmaceutical entity is an optimal addition to LGC. Benefits of the Transaction. The Transaction.

Pharmaceutical 45

Pharmaceutical Seed-To-Sale Compliance Compliance 45

Cannabis Law Report

AUGUST 29, 2021

This initial export to Brazil marks Avicanna ’s first commercial export of psychoactive Cannabis Extracts into the emerging Brazilian medicinal cannabis market and the delivery of the initial purchase order from the previously announced three (3) year master supply agreement.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

Cannabis Law Report

JUNE 22, 2021

AUSTIN, Texas–(BUSINESS WIRE)– Texas Original Compassionate Cultivation (TOCC), Texas’ leading medical cannabis provider, announced today the expansion of its product line to include Texas-inspired agave lime-flavored lozenges. About Texas Original Compassionate Cultivation.

Cultivation 66

Cultivation Tincture Patients Digestion 66

Cannabis Law Report

JULY 29, 2021

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. New progressive regulation on cannabis in Colombia. Expected benefits to Avicanna’s business units and infrastructure in Colombia.

Extraction 98

Extraction Supply Chain THC Research and Development 98

SpeedWeed

SEPTEMBER 17, 2021

The Farmer’s Wife celebrated the grand opening of its third dispensary in Missouri’s developing medical cannabis market Aug. Brodsky spent the last decade working in the cannabis industry in California and Colorado before returning home to Missouri shortly after the state legalized medical cannabis in 2018.

Cultivation 56

Cultivation Dispensary Retail Education 56

Cannabis Law Report

FEBRUARY 1, 2023

Cannabiz write Medicinal cannabis firm BBS Pharmaceuticals goes into administration BBS was licensed to cultivate and manufacture medicinal cannabis at its facility in regional South Australia, with plans to sell domestically and overseas. Looks like the conversation was over […]

Medicine 52

Medicine Pharmaceutical Cultivation Cannabis 52

Cannabis Law Report

JULY 7, 2021

A public cannabis company with a strong focus on the international market is stepping into Mexico’s nascent medical cannabis industry. In 2017, Mexico legalized medical cannabis with tetrahydrocannabinol (THC) concentrations below 1%. Detwiler said. “A A lot of these countries are just beginning their cannabinoid journey.”.

Pharmaceutical 105

Pharmaceutical Cannabinoids Cultivation Concentrates 105

Cannabis Law Report

SEPTEMBER 10, 2021

The Medical Cannabis Bill 399/2015, which aims to regulate the cultivation of industrial hemp and medical cannabis, and which has attracted opposition from a group of right-wing policymakers, is waiting for the deliberation of the Bureau of the Chamber of Deputies to advance to the next stage.

Policy 103

Policy Oil Concentrates Pharmaceutical 103

Veriheal

JULY 26, 2023

Georgia medical cannabis patients will soon have greater access to treatment as cannabis oil will be sold in many more pharmacies. The Georgia State Board of Pharmacy recently made the decision to endorse more cannabis oil sale outlets. Its conversion into low-THC cannabis oil also allowed for treating many diseases.

Oil 98

Oil Patients Access THC 98

Cannabis Law Report

DECEMBER 19, 2022

One of the country’s largest medicinal cannabis companies Australian Natural Therapeutics Group (ANTG) expects to quadruple its production capacity following the acquisition of a licensed cultivation and pharmaceutical manufacturing facility near the Brisbane Airport for an undisclosed sum.

Medicine 52

Medicine Pharmaceutical Cultivation Cannabis 52

Cannabis Law Report

AUGUST 6, 2021

Hemp Today reports… Proponents are optimistic that a proposed law that would establish a framework for medical cannabis and industrial hemp in Costa Rica could be in place by this autumn. The new law would legalize production including sowing, cultivation, harvesting, storage and transport of cannabis products.

Hemp 105

Hemp Programs Agriculture Environment 105

Cannabis Law Report

JUNE 4, 2022

Eastern Cape cannabis producer, Sweetwaters, has produced a ton of 26% THC flower to be exported to an Australian pharmaceutical client. The news will come as a relief to shareholders as Labat parted ways earlier this year with its initial SAHPRA-licensed cultivation partner, Leaf Botanicals in the Northern Cape.

THC 52

THC Pharmaceutical Research and Development Cultivation 52

Cannabis Law Report

SEPTEMBER 15, 2021

Four-time cancer survivor—and newly qualifying patient under the Texas Compassionate Use Program—joins TOCC staff to spread medical cannabis education and awareness among health care community. I still deal with chronic pain, but under Texas’ expanded medical cannabis program, my life is now on a trajectory I never thought possible.

Cultivation 52

Cultivation Chronic Pain Patients Education 52

Cannabis Law Report

JUNE 29, 2021

PUBLISHER: CANNABIS LAW REPORT. Segra International completes first export of Cannabis plantlets from Canada to the USA. This shipment marks a tremendous milestone in the evolution of the US cannabis industry, as it represents one of the first imports of live Cannabis plants to a federally licensed US cultivator.

Research and Development 102

Research and Development DEA Supply Chain Pharmaceutical 102

Cannabis Law Report

JULY 2, 2021

CannaVerde Pharma is a vertically integrated medical cannabis company with core operations in Colombia, focused on delivering low-cost, pharmaceutical grade, EU-GMP compliant cannabis-based products to consumers and medical patients in Latin America and Europe. July 28th, 2021. 12pm PST / 2pm CST / 3pm EST. CannaVerde Pharma.

Sleep 105

Sleep Pharmaceutical THC Extraction 105

The Cannigma

JUNE 14, 2021

For more than 50 years, if you wanted to do cannabis research in the United States, federal law said you had to get the cannabis from the University of Mississippi. The BRC is among the dozens of organizations that have received preliminary approval from the DEA to cultivate cannabis. Shutterstock).

DEA 133

DEA Research and Development Clinical Trials Pharmaceutical 133

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. It is expected to be worth USD 2.1

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

OCTOBER 19, 2019

A Slovenian cannabis company has listed on a junior London stock market raising over five million euros to fund its ambitious European growth plans. Freyherr International has 20 hectares of hemp cultivation in its home country and two hectares of medical cannabis growing in North Macedonia, which legalised medical cannabis in 2016.

Cultivation 45

Cultivation Hemp Research and Development Pharmaceutical 45

Cannabis Law Report

APRIL 28, 2022

DEMECAN’s first cannabis shipment to the BfArM is ready for collection and includes more than 100 kg of cannabis flowers. High-quality cannabis flowers from DEMECAN’s German high-end facility are now available to patients. 2500 cannabis plants are now growing in its own flower rooms in Saxony.

Pharmaceutical 52

Pharmaceutical Cultivation Collective Patients 52

Cannabis Law Report

NOVEMBER 10, 2021

Additionally, Verano has entered into definitive agreements to acquire both Caring Nature, LLC, which holds an active dispensary in Waterbury, Connecticut, and Connecticut Pharmaceutical Solutions, Inc., which holds an operating cultivation and production facility. mark of total cultivation capacity. CHICAGO, Nov.

Pharmaceutical 52

Pharmaceutical Dispensary Cultivation Collective 52

Cannabis Law Report

OCTOBER 28, 2021

The Government is backing a research and development programme to help accelerate the establishment of New Zealand’s medicinal cannabis industry and boost export potential. million, three-year programme led by project partner Greenlab, which aims to establish evidence-based medical cannabis cultivation practices.

Programs 52

Programs Research and Development Pharmaceutical Cultivation 52

Cannabis Law Report

JANUARY 28, 2022

By Maciej Konarowski, President of the Polish Medical Cannabis Patients Association and founder of the Can advocare law firm, and Conor O’Brien, Analyst at Prohibition Partners. Newly released data show that Poland is home to over 9,261 patients legally accessing medical cannabis, making it one of the largest such populations in Europe.

Legislation 52

Legislation Pharmaceutical Agriculture Cultivation 52

Cannabis Law Report

AUGUST 27, 2021

The Ministry of Health, Labor and Welfare has decided to issue a notification to prefectures in mid-September to ease regulations beyond rational guidance regarding industrial cannabis, which is being cultivated.

Pharmaceutical 98

Pharmaceutical Cultivation Data Policy 98

Cannabis Law Report

NOVEMBER 23, 2019

for the production R&D of pharmaceutical grade standardised cannabis. Here the company shares their evolution with Health Europa, exploring the production of pharmaceutical grade standardised cannabis. KANNABEIRA and standardised cannabis. Past achievements.

Pharmaceutical 45

Pharmaceutical Research and Development Cultivation Environment 45

Cannabis Law Report

MARCH 26, 2023

Senior Regulatory Affairs Associate Cann Group Limited Melbourne VIC Pharmaceuticals & Medical Devices (Healthcare & Medical) Full time Posted 2d ago About Cann Group Limited Cann Group Limited is enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines.

Research and Development 52

Research and Development Pharmaceutical Cultivation Medicine 52